Exploring the role and functionality of trial steering committees
暂无分享,去创建一个
P. Sandercock | S. Lewis | M. Sydes | D. Altman | S. Evans | C. Gamble | D. Elbourne | C. Baigent | J. Norrie | J. Bliss | G. Murray | M. Campbell | A. Lane | E. Conroy | N. Harman | S. Lewis | M. Campbell | Elizabeth J. Conroy
[1] Mike Clarke,et al. Good practice principles for sharing individual participant data from publicly funded clinical trials , 2015, Trials.
[2] S. Lewis,et al. Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences , 2015, Clinical trials.
[3] C. Gamble,et al. What Difference Does Patient and Public Involvement Make and What Are Its Pathways to Impact? Qualitative Study of Patients and Researchers from a Cohort of Randomised Clinical Trials , 2015, PloS one.
[4] G. Livingston,et al. Long-term clinical and cost-effectiveness of psychological intervention for family carers of people with dementia: a single-blind, randomised, controlled trial. , 2014, Lancet psychiatry.
[5] Deborah Buck,et al. From plans to actions in patient and public involvement: qualitative study of documented plans and the accounts of researchers and patients sampled from a cohort of clinical trials , 2014, BMJ Open.
[6] N. Britten,et al. Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis , 2014, The Lancet.
[7] R. Faria,et al. Continuous positive airway pressure in older people with obstructive sleep apnoea syndrome (PREDICT): a 12-month, multicentre, randomised trial. , 2014, The Lancet Respiratory Medicine.
[8] A. Gray,et al. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. , 2014, Lancet.
[9] N. Marlow,et al. Hot topics from the Assemblies , 2014, Breathe.
[10] T. Peters,et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. , 2014, The Lancet. Oncology.
[11] M. Sydes,et al. An ethnographic study of group decision making to understand and improve how trial steering committees contribute to trial conduct , 2013, Trials.
[12] S. Lewis,et al. Trial steering committees for randomised controlled trials: updating and redeveloping guidance and terms of reference informed by current practice and experience , 2013, Trials.
[13] S. Evans. When and How Can Endpoints Be Changed after Initiation of a Randomized Clinical Trial? , 2007, PLoS clinical trials.
[14] D. Spiegelhalter,et al. Issues in data monitoring and interim analysis of trials. , 2005, Health technology assessment.
[15] Sydes,et al. A proposed charter for clinical trial data monitoring committees: helping them to do their job well , 2005, The Lancet.
[16] D. Spiegelhalter,et al. Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials , 2004, Clinical trials.
[17] J. Wittes. On changing a long‐term clinical trial midstream , 2002, Statistics in medicine.